Hindustan Bio Sciences (BOM:532041) Cyclically Adjusted PS Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532041 Hindustan Bio Sciences Ltd BOM:532041
39 GF Score
Price ₹8.71
GF Value ₹3.14
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hindustan Bio Sciences Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hindustan Bio Sciences  (BOM:532041) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hindustan Bio Sciences Cyclically Adjusted PS Ratio Related Terms


Hindustan Bio Sciences Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Hindustan Bio Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences Cyclically Adjusted PS Ratio Chart

Hindustan Bio Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 2.41 3.54 3.22 0.00

Hindustan Bio Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.40 0.00 2.48 0.00 0.00

BOM:532041 vs ZTS: Cyclically Adjusted PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Cyclically Adjusted PS Ratio falls into.


BOM:532041
39GF Score
Hindustan Bio Sciences Ltd BOM:532041
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hindustan Bio Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hindustan Bio Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Hindustan Bio Sciences's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Hindustan Bio Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.340 105.961 0.537
201612 0.362 105.196 0.576
201703 0.301 105.196 0.479
201706 0.000 107.109 0.000
201709 0.071 109.021 0.109
201712 0.360 109.404 0.551
201803 0.574 109.786 0.875
201806 0.654 111.317 0.983
201809 1.265 115.142 1.839
201812 0.998 115.142 1.451
201903 0.468 118.202 0.663
201906 0.579 120.880 0.802
201909 0.137 123.175 0.186
201912 0.373 126.235 0.495
202003 1.167 124.705 1.566
202006 0.550 127.000 0.725
202009 0.333 130.118 0.428
202012 0.000 130.889 0.000
202103 0.164 131.771 0.208
202106 0.180 134.084 0.225
202109 0.000 135.847 0.000
202112 0.234 138.161 0.283
202203 -0.016 138.822 -0.019
202206 0.216 142.347 0.254
202209 0.000 144.661 0.000
202212 0.334 145.763 0.383
202303 0.292 146.865 0.333
202306 0.000 150.280 0.000
202309 0.287 151.492 0.317
202312 0.326 152.924 0.357
202403 0.390 153.035 0.427
202406 0.402 155.789 0.432
202409 0.402 157.882 0.426
202412 0.000 158.323 0.000
202503 0.383 157.552 0.407
202506 0.314 159.755 0.329
202509 0.000 162.289 0.000
202512 0.373 163.281 0.382
202603 0.000 164.272 0.000
202606 0.000 167.357 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?

Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued. The current stock price of ₹8.71 is trading 177.4% above its estimated GF Value™ of ₹3.14. GuruFocus considers Hindustan Bio Sciences to be Significantly Overvalued.

Key valuation signals for BOM:532041:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹3.14 vs. price of ₹8.71 (177.4% above fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hindustan Bio Sciences Business Description

Address Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
39GF Score

Get the complete analysis for BOM:532041

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.71
Price
₹3.14
GF Value